Not wrong but the process to extract the oil is the same for both. CBD oil whether for humans or animals is the same. Within Australia manufacture of CBD or other cannabinoids with or without THC and the odc licensing surrounding anything to do with cannabis is so complicated it does my head in. My reasoning and in all likelihood I'm wrong, was AEB would gain license to manufacture within Australia more readily for veterinary purposes and then MCL would/could piggyback from that. In the meantime rules/government regulation may change (as was seen with the export decision) so its anyone's guess what will happen. The deal btw AEB and MCL is mutually beneficial (opinion only) in setting up a local capacity to extract cannabinoids from whatever cultivars each entity has licensed access to for whichever licensed purpose each entity has.
AEB Price at posting:
5.5¢ Sentiment: Hold Disclosure: Held
